• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性血小板增多症伴门静脉血栓形成和脾梗死经血小板单采术成功治疗。

Essential thrombocythemia with portal vein thrombosis and splenic infarction successfully treated with platelet apheresis.

机构信息

Internal Medicine, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India.

Pathology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India.

出版信息

BMJ Case Rep. 2021 Sep 20;14(9):e245267. doi: 10.1136/bcr-2021-245267.

DOI:10.1136/bcr-2021-245267
PMID:34544722
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8454430/
Abstract

A 63-year-old diabetic woman presented to the outpatient clinic with a 1-week history of abdominal pain. On complete evaluation, she was diagnosed to have essential thrombocythemia. Abdominal imaging revealed portal vein thrombosis with a large splenic infarct. The patient was started on anticoagulant, antiplatelet and cytoreductive therapy. In view of persistent high platelet count, plasma apheresis was done, following which the patient's platelet counts were reduced. Essential thrombocythemia has a high rate of complications, resulting in significant morbidity and mortality. Few cases of this disease and its treatment have been described in the literature, especially pertaining to the Indian scenario. Further studies are needed to establish a multidisciplinary algorithm for its diagnosis and to elucidate the guidelines for the successful treatment of the condition.

摘要

一位 63 岁的糖尿病女性因腹痛就诊于门诊。经全面评估,她被诊断为原发性血小板增多症。腹部影像学显示门静脉血栓形成伴巨大脾梗死。患者开始接受抗凝、抗血小板和细胞减少治疗。鉴于血小板计数持续升高,进行了血浆置换,此后患者的血小板计数降低。原发性血小板增多症并发症发生率高,导致发病率和死亡率显著增加。该疾病及其治疗方法在文献中鲜有报道,特别是在印度的情况。需要进一步研究以建立其诊断的多学科算法,并阐明成功治疗该疾病的指南。

相似文献

1
Essential thrombocythemia with portal vein thrombosis and splenic infarction successfully treated with platelet apheresis.原发性血小板增多症伴门静脉血栓形成和脾梗死经血小板单采术成功治疗。
BMJ Case Rep. 2021 Sep 20;14(9):e245267. doi: 10.1136/bcr-2021-245267.
2
Portal, splenic, and superior mesenteric vein thrombosis in a patient with latent essential thrombocythemia and hyperhomocysteinemia.一名患有隐匿性原发性血小板增多症和高同型半胱氨酸血症患者的门静脉、脾静脉和肠系膜上静脉血栓形成。
J Clin Gastroenterol. 2006 Mar;40(3):227-8. doi: 10.1097/00004836-200603000-00012.
3
Acute splenic infarction presenting as an unusual manifestation of essential thrombocythaemia with normal platelet count.急性脾梗死表现为原发性血小板增多症的一种不寻常表现,血小板计数正常。
BMJ Case Rep. 2019 Jul 3;12(7):e229387. doi: 10.1136/bcr-2019-229387.
4
Cerebral infarct in a patient with a history of systemic arterial and venous thrombosis from essential thrombocythemia.特发性血小板增多症导致的动静脉系统血栓形成病史患者的脑梗死。
J Stroke Cerebrovasc Dis. 2012 Nov;21(8):913.e9-10. doi: 10.1016/j.jstrokecerebrovasdis.2012.01.005. Epub 2012 Feb 3.
5
Portal vein thrombosis due to essential thrombocythemia with limited cutaneous systemic sclerosis.由特发性血小板增多症伴局限性皮肤系统性硬皮病引起的门静脉血栓形成。
Clin J Gastroenterol. 2021 Feb;14(1):293-296. doi: 10.1007/s12328-020-01274-6. Epub 2020 Nov 2.
6
Successful management of VTE with essential thrombocythemia and cavernous transformation of the portal vein in early pregnancy: a case report.成功治疗早孕期特发性血小板增多症合并门静脉海绵样变性相关静脉血栓栓塞症:病例报告。
BMC Womens Health. 2024 Apr 2;24(1):211. doi: 10.1186/s12905-024-03051-w.
7
[A case of essential thrombocythemia associated with splenic infarction].
Nihon Naika Gakkai Zasshi. 1988 Mar;77(3):394-8. doi: 10.2169/naika.77.394.
8
Splenectomy in a case of splenic vein thrombosis unmasks essential thrombocythemia.脾静脉血栓形成病例中的脾切除术揭示了原发性血小板增多症。
Clin Lab Haematol. 2002 Apr;24(2):131-3. doi: 10.1046/j.1365-2257.2002.00234.x.
9
Portal Vein Thrombosis with Splenic Infarct in β-Thalassemia Minor at High Altitude.
High Alt Med Biol. 2020 Sep;21(3):310. doi: 10.1089/ham.2020.0054. Epub 2020 Jun 4.
10
[Splenoportal thrombosis: form of presentation of essential thrombocythemia].
An Med Interna. 1998 Nov;15(11):594-6.

引用本文的文献

1
Clinical, Hematological, Biochemical and Radiological Characteristics for Patients With Splenic Infarction: Case Series With Literature Review.脾梗死患者的临床、血液学、生化及影像学特征:病例系列及文献综述
J Clin Med Res. 2023 Jan;15(1):38-50. doi: 10.14740/jocmr4836. Epub 2023 Jan 24.

本文引用的文献

1
Emerging agents and regimens for polycythemia vera and essential thrombocythemia.真性红细胞增多症和原发性血小板增多症的新型药物及治疗方案
Biomark Res. 2021 May 28;9(1):40. doi: 10.1186/s40364-021-00298-5.
2
Thrombocytapheresis in Patient with Essential Thrombocythemia: A Case Report.原发性血小板增多症患者的血小板单采术:一例报告
Case Rep Oncol. 2020 Jun 16;13(2):675-679. doi: 10.1159/000507651. eCollection 2020 May-Aug.
3
Essential Thrombocythemia and Acquired von Willebrand Syndrome: The Shadowlands between Thrombosis and Bleeding.原发性血小板增多症与获得性血管性血友病综合征:血栓形成与出血之间的模糊地带
Cancers (Basel). 2020 Jun 30;12(7):1746. doi: 10.3390/cancers12071746.
4
Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management.真性红细胞增多症和原发性血小板增多症:2019 年诊断、风险分层和治疗更新。
Am J Hematol. 2019 Jan;94(1):133-143. doi: 10.1002/ajh.25303. Epub 2018 Nov 9.
5
The role of thrombocytapheresis in the contemporary management of hyperthrombocytosis in myeloproliferative neoplasms: A case-based review.血小板单采术在骨髓增殖性肿瘤高血小板血症当代管理中的作用:基于病例的综述。
Leuk Res. 2017 Jul;58:14-22. doi: 10.1016/j.leukres.2017.03.008. Epub 2017 Mar 22.
6
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.《临床实践中治疗性血液成分单采的使用指南——美国血液成分单采协会写作委员会基于证据的方法:第七期特刊》
J Clin Apher. 2016 Jun;31(3):149-62. doi: 10.1002/jca.21470.
7
Validation of the revised International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET-thrombosis) in 585 Mayo Clinic patients.验证改良的血栓形成特发性血小板增多症国际预后评分(IPSET-thrombosis)在 585 例 Mayo 诊所患者中的应用。
Am J Hematol. 2016 Jun;91(4):390-4. doi: 10.1002/ajh.24293.
8
Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with Budd-Chiari syndrome and/or portal vein thrombosis.JAK2 V617F突变对布加综合征和/或门静脉血栓形成患者潜在慢性骨髓增殖性疾病的诊断价值。
Turk J Gastroenterol. 2015 Jan;26(1):42-8. doi: 10.5152/tjg.2015.5738.
9
A latent form of essential thrombocythemia presenting as portal cavernoma.一种以门静脉海绵样变性为表现的特发性血小板增多症的潜在形式。
World J Gastroenterol. 2009 Nov 14;15(42):5368-70. doi: 10.3748/wjg.15.5368.
10
Portal vein thrombosis as the first sign of a primary myeloproliferative disorder: diagnostic interest of the V617F JAK-2 mutation. A report of 2 cases.门静脉血栓形成作为原发性骨髓增殖性疾病的首发症状:V617F JAK-2突变的诊断意义。2例报告
Acta Gastroenterol Belg. 2008 Jan-Mar;71(1):39-41.